Sagimet Biosciences Newsroom

Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksDec 8 16:41

JMP Securities Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Cuts Target Price to $31

Futu NewsDec 6 01:37

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsNov 21 21:33

Sagimet Biosciences Analyst Ratings

BenzingaNov 16 03:36

H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $32

Futu NewsNov 16 00:32

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsNov 15 21:31

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsNov 15 10:31

Sagimet Biosciences, Inc.: Strategic Advancements and Financial Robustness Drive Buy Rating

TipRanksNov 15 10:18

UBS Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $12

Futu NewsNov 12 18:33

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsOct 31 20:34

Sagimet Biosciences Analyst Ratings

BenzingaOct 31 17:40

H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $32

Futu NewsOct 31 00:32

Leerink Partners Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsOct 30 20:33

Sagimet Biosciences' Denifanstat Receives Buy Rating on FDA's BTD and Promising Trial Results

TipRanksOct 4 14:42

Sagimet Biosciences Analyst Ratings

BenzingaOct 2 19:14

HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $32 Price Target

BenzingaOct 2 19:14

Buy Rating for Sagimet Biosciences on Strong Phase 2b Results and Favorable Valuation Model

TipRanksOct 2 18:30

Buy Rating Justified: Sagimet Biosciences' Denifanstat Poised to Transform NASH Treatment Landscape

TipRanksOct 1 22:19

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsAug 20 19:31

TD Cowen Maintains Sagimet Biosciences(SGMT.US) With Buy Rating

Futu NewsAug 20 06:31